Global Premature Ejaculation Treatment Market (2018-2026): Market Size & Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Segment Forecasts - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 18, 2018--The “Global Premature Ejaculation Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026” report has been added to ResearchAndMarkets.com’s offering.
The global premature ejaculation treatment market was valued at US$ 1,666.1 Mn in 2017, and is expected to reach US$ 3,541.4 Mn by 2026, expanding at a CAGR of 8.8% from 2018 to 2026.
Currently the selective serotonin reuptake inhibitors dominate the premature ejaculation treatment market. It comprises of drugs such as sertraline, paroxetine, fluoxetine and citalopram. It has quick response as it reduces the serotonin uptake at presynaptic neuronal cells and increases the serotonin concentration at postsynaptic receptor cells, thereby delaying the intravaginal ejaculation time.
Topical anesthetic agents will showcase excellent growth during the forecast period owing to its availability as creams, sprays and condoms which provides climax control by controlling the afferent-efferent reflex pathway and delaying the ejaculation.
Oral route of administration is preferred by patients suffering with premature ejaculation disorder on account of faster onset of action and is popular among urologists to be prescribed for treating acute premature ejaculation disorder.
Topical route of administration is growing at a rapid pace due to better patient compliance and effectiveness in increasing the ejaculation latency time by reducing the sensitivity at glans penis.
Key Market HighlightsIncreasing number of patients suffering with premature ejaculation disorders Technological advancement in the preparation of anesthetic agents such as aerosol sprays and condoms to increase intravaginal latency time Rising public awareness regarding premature ejaculation in both patients and physicians
Key Topics Covered
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Premature Ejaculation Treatment Market: Dynamics and Future Outlook
Chapter 4. Global Premature Ejaculation Treatment Market, by Drug Class
Chapter 5. Global Premature Ejaculation Treatment Market, by Route of Administration
Chapter 6. Global Premature Ejaculation Treatment Market, by Geography
Chapter 7. Company ProfilesAbsorption Pharmaceuticals AstraZeneca Allergan plc Bayer AG Eli Lilly & Company GlaxoSmithkline plc Innovus Pharmaceutical Merck & Co. Inc. Pfizer Inc. Teva Pharmaceutical Industries Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/fn35rx/global_premature?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180918005501/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Sexual and Reproductive Health Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/18/2018 07:21 AM/DISC: 09/18/2018 07:20 AM